Alexandria Co. For Pharmaceuticals & Chemical Industries (EGX: AXPH)
Egypt
· Delayed Price · Currency is EGP 229.03
0.00 (0.00%)
At close: Sep 12, 2024
AXPH Balance Sheet
Financials in millions EGP. Fiscal year is July - June.
Millions EGP. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | 2018 - 2014 |
| Cash & Equivalents | 141.04 | 90.51 | 153.75 | 52.12 | 166.61 | 166.62 | Upgrade
|
| Cash & Short-Term Investments | 141.04 | 90.51 | 153.75 | 52.12 | 166.61 | 166.62 | Upgrade
|
| Cash Growth | -8.26% | -41.13% | 194.98% | -68.72% | -0.00% | 81.83% | Upgrade
|
| Accounts Receivable | 169.04 | 66.91 | 113.61 | 106.2 | 113.12 | 158.43 | Upgrade
|
| Other Receivables | 174.09 | 28.14 | 22.65 | 27.34 | 11.73 | 3.77 | Upgrade
|
| Receivables | 394.88 | 144.18 | 168.13 | 166.16 | 196.13 | 162.2 | Upgrade
|
| Inventory | 386.1 | 345.41 | 271.51 | 307.64 | 270.69 | 243.64 | Upgrade
|
| Prepaid Expenses | 0.27 | 0.27 | 0.36 | 0.05 | 0.19 | - | Upgrade
|
| Restricted Cash | - | - | 0 | 0.86 | 1.03 | - | Upgrade
|
| Other Current Assets | - | - | 0 | -0 | - | 0 | Upgrade
|
| Total Current Assets | 922.29 | 580.36 | 593.76 | 526.82 | 634.65 | 572.45 | Upgrade
|
| Property, Plant & Equipment | 368.92 | 340.24 | 279.06 | 264.29 | 165.96 | 114.61 | Upgrade
|
| Long-Term Investments | 2.39 | 2.39 | 2.39 | 2.39 | 2.39 | 2.39 | Upgrade
|
| Other Long-Term Assets | - | - | - | - | -0 | - | Upgrade
|
| Total Assets | 1,294 | 922.99 | 875.21 | 793.49 | 803 | 689.45 | Upgrade
|
| Accounts Payable | 351.02 | 139.28 | 160.86 | 92.14 | 102.61 | 109.52 | Upgrade
|
| Accrued Expenses | 7.75 | 4.16 | 4.32 | 6.45 | 5.13 | - | Upgrade
|
| Short-Term Debt | 3.52 | 12.03 | 9.11 | 1.77 | 7.84 | - | Upgrade
|
| Current Income Taxes Payable | - | - | - | - | - | 34.39 | Upgrade
|
| Current Unearned Revenue | 0.24 | 1.25 | - | - | - | - | Upgrade
|
| Other Current Liabilities | 145.54 | 91.7 | 78.13 | 99.48 | 106.87 | 54.93 | Upgrade
|
| Total Current Liabilities | 508.07 | 248.42 | 252.43 | 199.83 | 222.44 | 198.84 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 14.44 | 14.44 | 10.18 | 7.46 | 8.61 | 9.34 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | -0 | - | Upgrade
|
| Total Liabilities | 522.5 | 262.85 | 262.6 | 207.29 | 231.05 | 208.18 | Upgrade
|
| Common Stock | 50 | 50 | 50 | 50 | 50 | 50 | Upgrade
|
| Retained Earnings | 714.35 | 542.26 | 494.73 | 530.88 | 517.13 | 426.89 | Upgrade
|
| Comprensive Income & Other | 6.74 | 67.87 | 67.87 | 5.32 | 4.82 | 4.38 | Upgrade
|
| Shareholders' Equity | 771.09 | 660.14 | 612.6 | 586.2 | 571.95 | 481.27 | Upgrade
|
| Total Liabilities & Equity | 1,294 | 922.99 | 875.21 | 793.49 | 803 | 689.45 | Upgrade
|
| Total Debt | 3.52 | 12.03 | 9.11 | 1.77 | 7.84 | - | Upgrade
|
| Net Cash (Debt) | 137.52 | 78.48 | 144.63 | 50.35 | 158.77 | 166.62 | Upgrade
|
| Net Cash Growth | -4.92% | -45.74% | 187.27% | -68.29% | -4.71% | 103.56% | Upgrade
|
| Net Cash Per Share | 27.50 | 15.70 | 28.93 | 10.07 | 26.88 | 26.63 | Upgrade
|
| Filing Date Shares Outstanding | 5 | 5 | 5 | 5 | 5 | 5 | Upgrade
|
| Total Common Shares Outstanding | 5 | 5 | 5 | 5 | 5 | 5 | Upgrade
|
| Working Capital | 414.22 | 331.94 | 341.33 | 326.99 | 412.21 | 373.61 | Upgrade
|
| Book Value Per Share | 154.22 | 132.03 | 122.52 | 117.24 | 114.39 | 96.25 | Upgrade
|
| Tangible Book Value | 771.09 | 660.14 | 612.6 | 586.2 | 571.95 | 481.27 | Upgrade
|
| Tangible Book Value Per Share | 154.22 | 132.03 | 122.52 | 117.24 | 114.39 | 96.25 | Upgrade
|
| Land | 0.08 | 0.08 | - | 0.08 | 0.08 | 0.08 | Upgrade
|
| Buildings | 114.94 | 114.94 | - | 38.75 | 42.37 | 43.13 | Upgrade
|
| Machinery | 416.97 | 412.62 | - | 306.41 | 266.23 | 236.44 | Upgrade
|
| Construction In Progress | 136.94 | 85.31 | - | 134.55 | 62.82 | 20.4 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.